Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drugs, Investigational”

488 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 488 results

Testing effectiveness (Phase 2)Study completedNCT03350451
What this trial is testing

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Who this might be right for
PH1Primary HyperoxaluriaRNAi Therapeutic+2 more
Alnylam Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT00127192
What this trial is testing

An Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 363
Large-scale testing (Phase 3)Study completedNCT00090168
What this trial is testing

Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)

Who this might be right for
HypercholesterolemiaAtherosclerotic DiseaseCoronary Disease
Organon and Co 435
Large-scale testing (Phase 3)Study completedNCT03391882
What this trial is testing

An Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Who this might be right for
Motor OFF Episodes Associated With Parkinson's Disease
Sumitomo Pharma America, Inc. 113
Testing effectiveness (Phase 2)Ended earlyNCT05860296
What this trial is testing

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

Who this might be right for
Lung Cancer, Nonsmall CellLung Cancer Stage IVLung Cancer Metastatic
SignalChem Lifesciences Corporation 36
Not applicableStudy completedNCT03725813
What this trial is testing

Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit

Who this might be right for
Endocrine System DiseasesGastrointestinal Diseases
Göteborg University 177
Not applicableTemporarily pausedNCT00232323
What this trial is testing

Simulation Training as a Tool to Decrease Occupational Stress in ICU Personnel

Who this might be right for
Education, Health
Sheba Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Large-scale testing (Phase 3)Study completedNCT00895011
What this trial is testing

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

Who this might be right for
Erectile Dysfunction
VIVUS LLC 298
Testing effectiveness (Phase 2)Study completedNCT01101334
What this trial is testing

Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)
Daiichi Sankyo 90
Early research (Phase 1)Study completedNCT00454649
What this trial is testing

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Who this might be right for
Neoplasms
Pfizer 102
Not applicableStudy completedNCT01143207
What this trial is testing

PK of Depo SubQ Injected in the Upper Arm

Who this might be right for
Contraception
FHI 360 26
Early research (Phase 1)Study completedNCT01476800
What this trial is testing

Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult Volunteers

Who this might be right for
Healthy SubjectsPharmacokinetics of YM178
Astellas Pharma Inc 24
Not applicableEnded earlyNCT01600677
What this trial is testing

Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions

Who this might be right for
Medication AdherenceMedication NonadherenceAdverse Reaction to Drug
University of Pittsburgh 11
Testing effectiveness (Phase 2)Study completedNCT00097929
What this trial is testing

An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)

Who this might be right for
B-cell Lymphoma
Merck Sharp & Dohme LLC 18
Not applicableActive Not RecruitingNCT07118969
What this trial is testing

A Quasi-Experimental Study to Improve Breast Cancer Awareness Among University Students

Who this might be right for
Breast Cancer AwarenessHealth EducationEarly Detection of Cancer
Mardin Artuklu University 100
Testing effectiveness (Phase 2)Study completedNCT00122486
What this trial is testing

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Who this might be right for
HIV Infections
FHI 360 1,200
Early research (Phase 1)Study completedNCT05908383
What this trial is testing

Safety Study of GMDTC Injection in Healthy Participants

Who this might be right for
Cadmium Exposure
Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd. 76
Early research (Phase 1)Study completedNCT00557856
What this trial is testing

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 70
Testing effectiveness (Phase 2)Study completedNCT00512902
What this trial is testing

A Study Using The Experimental Drug Called Imatinib (Gleevec) in Subjects With Systemic Sclerosis

Who this might be right for
AlveolitisSystemic Sclerosis
University of California, Los Angeles 20
Load More Results